Effective at the close of business on Feb. 21, 2025, the common shares of Medicus Pharma Ltd. will be delisted from the TSX Venture Exchange at the request of the company.

The voluntary delisting has been accepted by the company's board of directors with a resolution dated Jan. 29, 2025.

For more information, please refer to the company's news release dated Feb. 11, 2025.

The exchange has been advised that the company's shares will continue trading on the Nasdaq Capital Market under the trading symbol MDCX.